Patent · US Active

Heterocyclic compounds

US11814375B2 · kind B2 · utility

1Cited by

6References

17Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Joerg Benz · Rheinfelden (Baden), DE
Luca Gobbi · Muttenz, CH
Uwe Grether · Weil am Rhein, DE
Katrin Groebke Zbinden · Liestal, CH
Benoit Hornsperger · Altkirch, FR
Carsten KROLL · Basel, CH
Bernd Kuhn · Sursee, CH
Rainer E. Martin · Basel, CH
Fionn O'Hara · Basel, CH
Bernd PUELLMANN · Aesch, CH
Hans Richter · Weil am Rhein, DE
Martin RITTER · Basel, CH

Key dates

Filing date	Sep 10, 2020
Grant date	Nov 14, 2023
Priority date	—
Expiry date	May 20, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D265/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L1, X, m, n, and R1 to R7 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.